Activist 13D/13G Filings - BELLICUM PHARMACEUTICALS INC (BLCM)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2019-08-26
5:02 pm
Purchase
13GBELLICUM PHARMACEUTICALS INC C
BLCM
Boxer Capital LLC5,133,600
9.99%
5,133,600increase
(New Position)
View
2019-08-22
4:09 pm
Unchanged
13DBELLICUM PHARMACEUTICALS INC C
BLCM
BAKER BROS. ADVISORS LP2,677,818
5.8%
0
(Unchanged)
View
2019-07-10
4:25 pm
Sale
13GBELLICUM PHARMACEUTICALS INC C
BLCM
BlackRock Inc.
BLK
1,265,899
2.8%
-1,669,609decrease
(-56.88%)
View
Goto Prev, 0, 1